MNOV Stock Predictions
| Recent MNOV Stock Price | MNOV Stock Predictions | |
| $2.47 |  +426.32% |
$13.00 |
| Recent MNOV Analyst Ratings Breakdown, Making MNOV Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 3 | 3 | 3 | 3 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the MNOV stock predictions from the analysts covering Medicinova Inc, we have collected all of the individual MNOV stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering MNOV (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MNOV stock predictions may vary widely, another useful metric to consider is the median MNOV stock prediction, which represents the price at which half of the analysts
made MNOV stock predictions that were higher and half made MNOV stock predictions that were lower. This makes for a different take on the MNOV stock predictions out there, as compared to average or mean.
And that median across all the individual MNOV stock predictions was: $6.0 as of 2023-01-27.
The very highest of the MNOV stock predictions for one year price target was $27.0, while the very lowest of the MNOV stock predictions in the analyst group was
$6.0 (with a standard deviation of $12.124). Get the latest Zacks research report on MNOV — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• MGIC Stock Predictions
• TPR Stock Predictions
• MXL Stock Predictions
• HHR Stock Predictions
• CSII Stock Predictions
• ESPR Stock Predictions
• SHSP Stock Predictions
• MDLZ Stock Predictions
• ARE Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 85th percentile
(ranked higher than approx. 85% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
